Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials
Objectives: This study aims to explore the weight loss effect and safety of semaglutide as a conventional anti-obesity drug systematically in obese or overweight patients without diabetes.Methods: The randomized controlled trials (RCTs) of semaglutide in obese or overweight patients without diabetes...
Saved in:
Main Authors: | Xueqin Gao (Author), Xiaoli Hua (Author), Xu Wang (Author), Wanbin Xu (Author), Yu Zhang (Author), Chen Shi (Author), Ming Gu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of information-intelligence technologies in pharmacy intravenous admixture services in a Chinese third-class a hospital
by: Xu Wang, et al.
Published: (2022) -
Effect of semaglutide and liraglutide in individuals with obesity or overweight without diabetes: a systematic review
by: You Deng, et al.
Published: (2022) -
Semaglutide in Overweight and Obese patients: Cardiovascular and/or Renal Metabolic Benefits
by: Jorge Rico-Fontalvo, et al.
Published: (2022) -
Cardiovascular effects of weight loss in old adults with overweight/obesity according to change in skeletal muscle mass
by: Xiaojie Cai, et al.
Published: (2024) -
Semaglutide for the treatment of obesity
by: Rafał Oleszczuk, et al.
Published: (2022)